Preventing severe respiratory syncytial virus disease: passive, active immunisation and new antivirals.
about
A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein.RSV vaccine use--the missing data.Pediatric infectious diseases: getting research evidence into practice and generation of new evidence.Evaluation of case definitions for estimation of respiratory syncytial virus associated hospitalizations among children in a rural community of northern India.Revised recommendations concerning palivizumab prophylaxis for respiratory syncytial virus (RSV)Respiratory Syncytial Virus-associated hospitalization in premature infants who did not receive palivizumab prophylaxis in Italy: a retrospective analysis from the Osservatorio StudyImmunogenicity of RSV F DNA Vaccine in BALB/c Mice.Product review on the monoclonal antibody palivizumab for prevention of respiratory syncytial virus infection.Commercially available immunoglobulins contain virus neutralizing antibodies against all major genotypes of polyomavirus BK.Single-dose treatment with a humanized neutralizing antibody affords full protection of a human transgenic mouse model from lethal Middle East respiratory syndrome (MERS)-coronavirus infectionInhibition of Respiratory Syncytial Virus Replication by Simultaneous Targeting of mRNA and Genomic RNA Using Dual-Targeting siRNAs.Burden of paediatric respiratory syncytial virus disease and potential effect of different immunisation strategies: a modelling and cost-effectiveness analysis for England.
P2860
Q30379384-32AE0BF2-4928-46C1-BC7F-A31FC93110CBQ31030277-5CF9942A-ED7E-4AD6-AD7A-490E171E362CQ34651007-BE3251FD-1D7C-4B78-982B-57112112358AQ36299475-BAAC1763-DA53-430A-9072-EB1FB48BB23FQ36376822-7C09A196-F7DD-429D-AD1B-870458D21C58Q36837007-01E3287F-F624-4A15-B7DC-E1D10B712C14Q37263840-D77E23AF-4425-492F-9749-207F9DE72AD2Q38671952-3838CE4E-A738-4365-873B-0EA9D984E89FQ38904012-56CF8C55-7122-42BB-AE21-402D9C1EEC9AQ39677274-E0EB3213-0219-4AE4-AFC8-AFF4559FD1DDQ40476115-E2A14E35-5F38-4C0B-980B-D596419FB658Q53693691-E7C63873-6064-4342-B928-7E1F175EA6DA
P2860
Preventing severe respiratory syncytial virus disease: passive, active immunisation and new antivirals.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Preventing severe respiratory ...... munisation and new antivirals.
@en
type
label
Preventing severe respiratory ...... munisation and new antivirals.
@en
prefLabel
Preventing severe respiratory ...... munisation and new antivirals.
@en
P2860
P1476
Preventing severe respiratory ...... mmunisation and new antivirals
@en
P2093
Joanna Murray
P2860
P304
P356
10.1136/ARCHDISCHILD-2013-303764
P407
P577
2014-01-24T00:00:00Z